PBYI FY 2024 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$311M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$230M-2.2% YoY

Gross Profit

$166M72.1% margin

Operating Income

$31M13.4% margin

Net Income

$30M13.1% margin

EPS (Diluted)

$0.62

Cash Flow

Operating Cash Flow

$39M

Free Cash Flow

$39M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$213M

Total Liabilities

$121M

Stockholders' Equity

$92M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$230M	$236M	-2.2%
Gross Profit	$166M	$173M	-4.0%
Operating Income	$31M	$33M	-5.1%
Net Income	$30M	$22M	+40.2%